What question did this study set out to answer?

To correct the funding information associated with the study on nab-PTX and anti-PD-1 antibody against lung cancer.

March 6, 2026Frontiers in OncologyOpen Access

Correction: Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating Pi3K/AKT pathway through the Serpinc1 gene

View Full Paper

Ask AI

Bookmark

Authors

Corrigendum reports funding error in study combining nab-PTX and anti-PD-1 against lung cancer, indicating funding implications.

To correct the funding information associated with the study on nab-PTX and anti-PD-1 antibody against lung cancer.
Identification of an error in the original funding statement.
Correction of the funding number from an acceptance number to an approval number.
The correct funding number is 82173892 instead of 8217130423.

Zhang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark